C71T
CANCELLED SECTION 71
12/06/2026
Voltar para busca
Dado oficial do USPTO
URENIDY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
50
Atualização mais recente
07/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
20/03/2019
Data de registro
26/11/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/06/2026
Última transação
07/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
98
Localização do titular
JP
Examinador
SMITH, REBECCA A
Unidade examinadora
M10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Sumitomo Pharma Co., Ltd.
Urovant Sciences GmbH
Representantes
Jeffrey R. Cadwell Dorsey & Whitney LLP
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for human use for the prevention of urologicalurinary tract systemsreproductive organ diseases and disorders; Pharmaceutical preparations for human use for the treatment of urologicalurinary tract systemsreproductive organ diseases and disorders; Biological and pharmaceutical preparations for medical and therapeutic use for the prevention of urologicalurinary tract systemsreproductive organ diseases and disorders; Biological and pharmaceutical preparations for medical and therapeutic use for the treatment of urologicalurinary tract systemsreproductive organ diseases and disorders; Pharmaceutical preparations for treatment of bladder and urinary conditions; Pharmaceutical preparations for treatment of overactive bladder
Publicações
Histórico de despachos e eventos da marca no USPTO.
50 publicações encontradas
CHLD
CHANGE OF OWNER RECEIVED FROM IB
16/04/2026
NREP
NEW REPRESENTATIVE AT IB RECEIVED
13/03/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
26/11/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/10/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/10/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/10/2024
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
12/04/2024
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
12/04/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/04/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
08/04/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/04/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/04/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/04/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/04/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
23/02/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
18/03/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/11/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
29/04/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
28/03/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/03/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
28/03/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/03/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/03/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
28/03/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/04/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
14/03/2020
FIMP
FINAL DISPOSITION PROCESSED
14/03/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
26/02/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
26/11/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/09/2019
PUBO
PUBLISHED FOR OPPOSITION
10/09/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21/08/2019
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
30/07/2019
RFNT
REFUSAL PROCESSED BY IB
27/07/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
26/07/2019
ALIE
ASSIGNED TO LIE
15/07/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/06/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/06/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/06/2019
RFRR
REFUSAL PROCESSED BY MPU
22/06/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/06/2019
MAFR
APPLICATION FILING RECEIPT MAILED
01/06/2019
CNRT
NON-FINAL ACTION WRITTEN
31/05/2019
DOCK
ASSIGNED TO EXAMINER
30/05/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/05/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
23/05/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace URENIDY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.